• New Partnership Announced to Deliver New Bioequivalence Solution for Pharmaceutical and Contract Research Organisations

News

New Partnership Announced to Deliver New Bioequivalence Solution for Pharmaceutical and Contract Research Organisations

Thermo Fisher Scientific Inc., announces a new strategic partnership with Megaware, a life science technology organisation, to deliver a new bioanalysis/equivalence solution and joint support services for pharmaceutical, biotech and Contract Research Organizations (CROs).

Under the terms of the collaboration, Thermo Fisher and Megaware will market a new comprehensive end-to-end software solution which provides bioequivalence functionality on a single platform to help speed up and manage clinical trials. Rapid market growth in generic drug production is driving the requirement for fast efficient bioequivalence studies to meet FDA ANDA guidelines (Abbreviated New Drug Applications). A unified software solution will aggregate disparate software systems for organizations that demand tools to speed service and management of this critical and regulated IPO.

The two companies will work together closely to target the market for bioanalysis/equivalence studies, initially in India and thereafter across the Far East and other markets. The market in India for clinical trials is growing rapidly, because the average cost of trials is significantly lower than in the United States and Europe. The consultancy firm McKinsey estimates that US and European pharmaceutical companies will spend US $1.5 billion per year on clinical trials in India by 2010.

Thermo Fisher and Megaware will jointly sell, market and support the new solution in the field. Thermo Fisher will bring its bioanalytical expertise to the partnership and Megaware, with headquarters in Westborough, MA and Mumbai, India, will deliver the end-to-end technological focus combined with on-the-ground market knowledge. The new solution will offer higher throughput, greater levels of compliance and standardisation of bioequivalence processes.

Digital Edition

ILM 50.3 April 2025

May 2025

Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...

View all digital editions

Events

Future Labs Live Basel 2025

May 27 2025 Basel, Switzerland

ASMS Conference

Jun 01 2025 Baltimore, MD, USA

Chemspec Europe 2025

Jun 04 2025 Koeln, Germany

Lab & Test Asia

Jun 11 2025 Bangkok, Thailand

HPLC 2025

Jun 15 2025 Bruges, Belgium

View all events